Invus
Crossover fundNew York · Pre-Seed–Late Stage · 6 people tracked
Also known as INVUS FINANCIAL ADVISORS, LLC
Investment thesis
Invus combines the long time horizon and personal attention of a family office with the capabilities of a multi-strategy firm. Anchored by a continuous capital structure funded by Artal since 1985, it invests without predetermined exit timelines, allowing it to support companies from early stages through public-company status. The private equity team makes a handful of transformational investments each year as sole or lead partner, holding minority or majority stakes. The public equity team runs a concentrated long-only portfolio with multi-year holds. Invus Opportunities invests globally in private technology businesses across fintech, marketplaces, healthcare, AI/software, and other tech-enabled sectors. The firm emphasizes alignment, avoiding transaction and monitoring fees.
Source: firm website, verified Aug 18, 2026.
Team · 6 people
from the firm's website & public directoriesWhat they invest in
from 7 of 7 portfolio companiesBiotech ×3AI & Machine Learning ×2B2B Marketplaces ×1Crypto & Web3 ×1Data & Infrastructure ×1Deep Tech ×1Enterprise Software ×1Fintech ×1
HQs:United States×4Japan×1Kenya×1
Investments · 7 tracked
founders shown can be your intro pathAbsci is a generative AI drug creation company that uses its Integrated Drug Creation platform, combining AI models and wet-lab validation, to design biologics against difficult-to-drug targets.
AI & Machine LearningBiotechDeep TechPortland, US
Sean McClain(Executive Officer)Phil Barish(Executive Officer)
BoardZach Jonasson(Director)Daniel Gold(Director)Bryan Lawlis(Director)
Co-investorsDas & Co.Oregon Venture FundPhoenix Venture PartnersTachyon VenturesTau VenturesBiotechnology Value Fund+2 more
Flare provides software infrastructure and operational support for emergency response teams in government and private sectors, enabling real-time resource management, location tracking, and coordination across multiple agencies to improve response times and effectiveness.
Enterprise SoftwareGovTechSaaSNairobi, KE
Co-investors4Di CapitalInovia CapitalAgent CapitalCasdin CapitalNextech InvestPfizer Ventures+2 more
Flare is a layer 1 blockchain designed for data-intensive decentralized applications, providing enshrined data protocols and infrastructure for developers building with on-chain data.
Crypto & Web3Data & Infrastructure
Co-investorsDigital Currency GroupAgent CapitalCasdin CapitalInovia CapitalNextech InvestPfizer Ventures+2 more
Flare develops AI-driven systems to manage essential workers—such as drivers, cleaners, security guards, and domestic workers—in emerging markets, vertically integrating its technology platform, worker staffing (via subsidiary Drive-Z), and customer implementation.
AI & Machine LearningFuture of WorkHR TechTokyo, JP
Kazuki Kamiya(CEO)Satoru Ichihara(COO)Shinya Hayashi(CSO)Hidefumi Iwaki(CFO)Tomohiro Sasaki(Executive Officer (Product Development))
Co-investorsANOBAKACARTA VENTURES, Inc.Spiral VenturesAgent CapitalBase10 PartnersCasdin Capital+5 more
BiotechCambridge, US
Geoff McDonoughy(Executive Officer, Director)Glenn Goddard(Executive Officer)Mark Angelino(Executive Officer)
BoardJason Rhodes(Director)inCatherine Stehman-Breen(Director)Anthony Quinn(Director)
Co-investorsAtlas VentureForesite CapitalF-Prime Capital Partners
Lycia Therapeutics is a biotechnology company developing LYTAC (Lysosomal Targeting Chimera) therapeutics that bind disease-causing extracellular and cell-surface proteins and route them into the cell's lysosome for degradation.
BiotechHealthtechSouth San Francisco, US
Aetna Wun Trombley(President and CEO)Amy Bachrodt(Chief Financial Officer)Jeremy S. Caldwell(Executive Officer, Director)Chin Lee(Chief Medical Officer)Steve Staben(Chief Scientific Officer)Sofia Touami(Chief Business Officer)
Co-investorsREDMILEVersant VenturesBAM ElevateFranklin TempletonHBM Healthcare InvestmentsJanus Henderson Investors+4 more
PayJoy provides financial services and credit access to unbanked and underbanked populations in emerging markets across Africa, Asia, and Latin America.
B2B MarketplacesFintechImpact & Social GoodRetail TechSan Francisco, US
Douglas Ricket(Executive Officer, Director)Mark Heynen(Co-Founder (early team))Doug Ricket(Co-Founder & CEO)Gib Lopez(Co-Founder & COO)Tom Ricket(Co-Founder (early team))Nick Zakrasek(President, Product Development)
Co-investorsCeniarthCiti VenturesCompoundCore Venture CapitalDnx VenturesEchoVC Partners+17 more
Exits · 1
IPOs and acquisitions across the tracked portfolioAbsciNASDAQ: ABSI
Portfolio news
latest coverage across their companiesFlare · coindesk.com · Jul 30, 2026
Payjoy 低所得者層向けファイナンシングプラットフォーム · Forbes · Jul 24, 2026
Lycia Therapeutics · intelligence360.news · Jul 22, 2026
Flare · allsci.com · Jul 1, 2026
Flare · allsci.com · Jul 1, 2026
Absci · investing.com · Jun 25, 2026
Generation Bio · ad-hoc-news.de · May 20, 2026
Frequently asked questions
- What stage does Invus invest at?
- Invus invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Invus focus on?
- Invus focuses on AI & Machine Learning, Biotech, Consumer, Crypto & Web3, Fintech, FoodTech, Healthtech, Marketplaces, SaaS, Travel & Hospitality.
- Where is Invus located?
- Invus is headquartered in New York, US.
- Who does Invus co-invest with?
- Invus most often shares deals with Citi Ventures, Compound, EchoVC Partners, among 21 tracked co-investors.
Similar investors
AppWorks is a Taiwan-based venture capital firm and accelerator founded by former founders that backs early- to growth-stage tech startups, running an accelerator program, investment funds, and a tech-skills school.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
Norwest is a venture and growth equity investment firm that has backed over 700 companies across sectors including AI, retail, and healthcare over its 65-year history.
Notable Capital is a venture capital firm that has partnered with founders for over two decades, backing companies from the earliest stages through to exit.
Everywhere Ventures is an early-stage venture firm that backs founders globally, supported by a community of founders and operators as LPs.